PR Newswire is a distributor of press releases headquartered in New York City. The service was created in 1954 to allow companies to electronically send press releases to news organizations, at first using teleprinters. The founder, Herbert Muschel, operated the service from his house in Manhattan for approximately 15 years. The business was eventually sold to Western Union and then United Newspapers of London. In December 2015, Cision Inc. acquired the company.
Logo as of January 2017
|Founded||March 8, 1954|
PR Newswire was founded in March 1954. In 1971, it was sold to Western Union, which had provided the telecommunications lines and teleprinters that supported the service. In 1977, PR Newswire began using electronic terminals for copyediting.
In 2000 the company acquired eWatch, founded in 1995 as an automated service to monitor websites, chat rooms, Usenet groups, web publications, online service forums and investor message boards for mentions of a specific organization, issue, product or service. In 2001, PR Newswire issued the first Multimedia News Release for Touchstone Pictures promoting the film Pearl Harbor. The Multimedia News Release was the first press release to include b-roll, soundbites, high resolution images, and film trailer. On April 17, 2007, PR Newswire acquired Vintage Filings.
In December 2008, PR Newswire moved its New York City corporate headquarters from Midtown Manhattan to Lower Manhattan, at 350 Hudson Street. In mid-2009, PR Newswire acquired The Fuel Team. The largest competitor to PR Newswire is Business Wire. On December 15, 2015, PR Newswire was sold to global media intelligence company, Cision, for $841 million. The transaction, which required approval by the shareholders of UBM plc as well as regulatory approvals, was expected to close late in the first quarter of 2016. As of June 2016 (closing date of the deal) it became a subsidiary of Cision. As of 2013, the PR newswire database includes 10,700 syndicated websites and has 800,000 journalists and influencers in its network.
Allergan plc is an Irish–tax registered pharmaceutical company that acquires, develops, and markets branded drugs, and in 2017 generated 80% net sales from the U.S. healthcare system. Allergan plc was formed in February 2015 when Irish–registered Actavis plc acquired U.S.–registered Allergan, Inc., and assumed the Allergan name. Actavis was a 2013 U.S. corporate tax inversion who moved to Ireland to avoid U.S. taxes on their income, almost all of which came from the U.S. healthcare system. Actavis used the Irish low-tax corporate system to acquire large U.S. pharmaceutical firms (e.g. Forest Labs, Allergan Inc.), and redomicile them to Ireland. In 2016, the U.S. blocked Actavis from executing what would have been the largest corporate tax inversion in history with Pfizer.Using Ireland's low-tax regime, Allergan acquires, develops, reprices, and markets branded products in six therapeutic areas: aesthetics/dermatology/plastic surgery; neurosciences/CNS; eye care; women’s health and urology; GI and cystic fibrosis; and cardiovascular disease and infectious disease. The company's products include Botox (botulinum toxin), Namenda (memantine), Restasis (ciclosporin), Linzess (linaclotide), Bystolic (nebivolol), Juvederm (injectable filler), Latisse (bimatoprost), Lo Loestrin Fe, Estrace (estradiol), Teflaro (ceftaroline fosamil), Dalvance (dalbavancin, Ozurdex (dexamethasone), Optive, Natrelle, Viibryd (vilazodone), Liletta (levonorgestrel), Saphris (asenapine), Enablex (darifenacin), Actonel (risedronic acid), Androderm (testosterone), and Gelnique (oxybutynin).